Roberts-Thomson P J, Walker J G, Lu T Y-T, Esterman A, Hakendorf P, Smith M D, Ahern M J
Department of Immunology, Allergy and Arthritis, Flinders Medical Center, Adelaide, South Australia, Australia.
Intern Med J. 2006 Aug;36(8):489-97. doi: 10.1111/j.1445-5994.2006.01125.x.
The aim of this study was to determine the incidence, prevalence, survival and selective demographic characteristics of scleroderma occurring in South Australia over the 10-year period 1993-2002. Analysis of the database of the South Australian Scleroderma Register: a population-based register established in 1993. Patients with scleroderma resident in South Australia (n = 353 at 2002) were ascertained from multiple sources and clinical and demographic data were obtained from mailed questionnaire and from review of computerized hospital databases, case notes or referring letters. Time-space cluster analysis was carried out according to the Knox method. Control data were obtained from the Australian Bureau of Statistics census. The mean prevalence was 21.4 per 10(5) (95% confidence interval 20.2-22.6) and the mean cumulative incidence of 1.5 per 10(5) (95% confidence interval 1.32-1.73) with no significant change in incidence over the study period (P = 0.13). Cumulative survival improved over the study period, with patients with diffuse disease having significantly reduced survival (as compared with limited disease, P < 0.001). The proportion with diffuse disease ( approximately 22%) remained steady. There was a small but significant predisposition in patients with a continental European birthplace (P < 0.001). A family history of scleroderma was noted in 1.6% with lambda1 (familial risk) of 14.3 (95% confidence interval 5.9-34.5). However, a family history of systemic autoimmunity (especially rheumatoid arthritis) was more common (6%). No socioeconomic stratification, temporal clustering nor spatio-temporal clustering was observed either at time of initial symptom or at 10 years before disease onset. Scleroderma occurs relatively infrequently in South Australia with no significant change in incidence observed over the 10-year study period. However, cumulative survival has improved. Identified risk factors include family history of scleroderma (risk approximately 14-fold), female sex (risk approximately 5-fold) and European birthplace (risk approximately 2.5-fold); however, the majority of the disease variance appears unexplained. A stochastic explanation based on genetic instability is favoured to explain this paradox.
本研究旨在确定1993年至2002年这10年间南澳大利亚州硬皮病的发病率、患病率、生存率及选择性人口统计学特征。分析南澳大利亚州硬皮病登记数据库:这是一个于1993年建立的基于人群的登记库。通过多种来源确定居住在南澳大利亚州的硬皮病患者(2002年时为353例),并通过邮寄问卷以及查阅计算机化医院数据库、病历或转诊信函获取临床和人口统计学数据。根据诺克斯方法进行时空聚类分析。对照数据来自澳大利亚统计局的人口普查。平均患病率为每10万分之21.4(95%置信区间20.2 - 22.6),平均累积发病率为每10万分之1.5(95%置信区间1.32 - 1.73),在研究期间发病率无显著变化(P = 0.13)。在研究期间累积生存率有所改善,弥漫型疾病患者的生存率显著降低(与局限型疾病相比,P < 0.001)。弥漫型疾病患者的比例(约22%)保持稳定。出生于欧洲大陆的患者存在小但显著的易感性(P < 0.001)。1.6%的患者有硬皮病家族史,λ1(家族风险)为14.3(95%置信区间5.9 - 34.5)。然而,系统性自身免疫病(尤其是类风湿关节炎)家族史更为常见(6%)。在初始症状出现时或疾病发作前10年,均未观察到社会经济分层、时间聚类或时空聚类现象。硬皮病在南澳大利亚州相对不常见,在10年研究期间发病率无显著变化。然而,累积生存率有所提高。已确定的风险因素包括硬皮病家族史(风险约为14倍)、女性(风险约为5倍)以及出生于欧洲(风险约为2.5倍);然而,大多数疾病差异似乎无法解释。基于基因不稳定性的随机解释更有利于解释这一矛盾现象。